Published in Invest Ophthalmol Vis Sci on June 22, 2011
Nicotine increases the VEGF/PEDF ratio in retinal pigment epithelium: a possible mechanism for CNV in passive smokers with AMD. Invest Ophthalmol Vis Sci (2011) 0.97
Nicotine and pathological angiogenesis. Life Sci (2012) 0.87
Pathogenesis of abdominal aortic aneurysms: role of nicotine and nicotinic acetylcholine receptors. Mediators Inflamm (2012) 0.82
The effect of nicotine on anti-vascular endothelial growth factor therapy in a mouse model of neovascular age-related macular degeneration. Retina (2012) 0.75
UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis. Diabetologia (2001) 4.78
Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis. Nat Med (2001) 4.56
Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells. J Clin Invest (2003) 4.06
Management of diabetic retinopathy: a systematic review. JAMA (2007) 3.47
Prospective study of cigarette smoking, alcohol use, and the risk of diabetes in men. BMJ (1995) 3.37
Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. Biochem Pharmacol (2007) 3.19
Neuronal nicotinic receptors: from structure to pathology. Prog Neurobiol (2004) 3.17
Fundamental concepts of the angiogenic process. Curr Mol Med (2003) 3.16
Matrix metalloproteinases (MMPs) in health and disease: an overview. Front Biosci (2006) 2.81
A novel angiogenic pathway mediated by non-neuronal nicotinic acetylcholine receptors. J Clin Invest (2002) 2.19
Second hand smoke stimulates tumor angiogenesis and growth. Cancer Cell (2003) 2.17
Nicotine induces cell proliferation by beta-arrestin-mediated activation of Src and Rb-Raf-1 pathways. J Clin Invest (2006) 2.15
Nicotine inhibits apoptosis induced by chemotherapeutic drugs by up-regulating XIAP and survivin. Proc Natl Acad Sci U S A (2006) 2.10
The association between cigarette smoking and ocular diseases. Surv Ophthalmol (1998) 2.10
Cigarette smoking and the risk of diabetes in women. Am J Public Health (1993) 1.95
Matrix metalloproteinases in early diabetic retinopathy and their role in alteration of the blood-retinal barrier. Lab Invest (2005) 1.92
Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy. Curr Diabetes Rev (2006) 1.92
Nicotinic acetylcholine receptors in cancer: multiple roles in proliferation and inhibition of apoptosis. Trends Pharmacol Sci (2008) 1.90
Cigarette smoking and diabetic retinopathy. Diabetes (1977) 1.71
Nicotine-mediated cell proliferation and angiogenesis: new twists to an old story. Cell Cycle (2006) 1.66
Endothelial sprouting and angiogenesis: matrix metalloproteinases in the lead. Cardiovasc Res (2007) 1.56
Nicotine inhibits apoptosis and stimulates proliferation in aortic smooth muscle cells through a functional nicotinic acetylcholine receptor. J Surg Res (2007) 1.51
The 25-year incidence of visual impairment in type 1 diabetes mellitus the wisconsin epidemiologic study of diabetic retinopathy. Ophthalmology (2009) 1.47
Nicotine promotes arteriogenesis. J Am Coll Cardiol (2003) 1.42
Nicotine increases size and severity of experimental choroidal neovascularization. Invest Ophthalmol Vis Sci (2004) 1.38
Matrix metalloproteinase control of capillary morphogenesis. Crit Rev Eukaryot Gene Expr (2008) 1.32
Cigarette-smoking as a risk factor for macroproteinuria and proliferative retinopathy in type 1 (insulin-dependent) diabetes. Diabetologia (1986) 1.26
Angiogenesis and the role of the endothelial nicotinic acetylcholine receptor. Life Sci (2007) 1.26
Matrix metalloproteinase-2 dysregulation in type 1 diabetes. Diabetes Care (2007) 1.23
Role of matrix metalloproteinase-9 in the development of diabetic retinopathy and its regulation by H-Ras. Invest Ophthalmol Vis Sci (2010) 1.21
Elevated circulating levels of matrix metalloproteinase-9 in type 1 diabetic patients with and without retinopathy. Clin Chim Acta (2006) 1.18
The prevalence of diabetic retinopathy and maculopathy and their risk factors in the non-insulin-treated diabetic patients of an English town. Eye (Lond) (1993) 1.15
Screening for and managing diabetic retinopathy: current approaches. Am J Health Syst Pharm (2007) 1.14
Reduced retinal angiogenesis in MMP-2-deficient mice. Invest Ophthalmol Vis Sci (2003) 1.14
Nicotine and angiogenesis: a new paradigm for tobacco-related diseases. Ann Med (2004) 1.13
Matrix metalloproteinases in human diabetic and nondiabetic vitreous. Retina (2001) 1.12
Promising new treatments for neovascular age-related macular degeneration. Expert Opin Investig Drugs (2006) 1.11
Production and activation of matrix metalloproteinase-2 in proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci (2003) 1.09
Impaired retinal angiogenesis in diabetes: role of advanced glycation end products and galectin-3. Diabetes (2005) 1.08
Mecamylamine suppresses Basal and nicotine-stimulated choroidal neovascularization. Invest Ophthalmol Vis Sci (2008) 1.06
Angiogenic activity of nicotinic acetylcholine receptors: implications in tobacco-related vascular diseases. Pharmacol Ther (2008) 1.05
Cigarette smoking and ten-year progression of diabetic retinopathy. Ophthalmology (1996) 1.03
Increased circulatory MMP-2 and MMP-9 levels and activities in patients with type 1 diabetes mellitus. Mt Sinai J Med (2006) 1.00
Association of cigarette smoking with diabetic retinopathy. Diabetes Care (1991) 0.99
Capsaicin displays anti-proliferative activity against human small cell lung cancer in cell culture and nude mice models via the E2F pathway. PLoS One (2010) 0.99
Cigarette smoking as a risk factor for atherosclerosis and renal disease: novel pathogenic insights. Curr Hypertens Rep (2007) 0.98
Matrix metalloproteinase-2 expression and apoptogenic activity in retinal pericytes: implications in diabetic retinopathy. Ann N Y Acad Sci (2007) 0.97
Inhibition of retinal angiogenesis by peptides derived from thrombospondin-1. Invest Ophthalmol Vis Sci (2000) 0.96
Microvascular retinopathy in the Zucker diabetic fatty rat. Invest Ophthalmol Vis Sci (1993) 0.95
Inhibitory effects of arresten on bFGF-induced proliferation, migration, and matrix metalloproteinase-2 activation in mouse retinal endothelial cells. Curr Eye Res (2010) 0.95
Plasma levels of matrix metalloproteinase-2 and -9 (MMP-2 and MMP-9) in age-related macular degeneration. Eye (Lond) (2008) 0.93
Nicotine reorganizes cytoskeleton of vascular endothelial cell through platelet-derived growth factor BB. J Surg Res (2000) 0.93
Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP). Biochem J (2003) 0.92
Genetic variations and plasma levels of gelatinase A (matrix metalloproteinase-2) and gelatinase B (matrix metalloproteinase-9) in proliferative diabetic retinopathy. Mol Vis (2008) 0.90
Nicotine-induced smooth muscle cell proliferation is mediated through bFGF and TGF-beta 1. Surgery (2000) 0.90
Eye disorders in diabetes: potential drug targets. Infect Disord Drug Targets (2008) 0.89
Matrix metalloproteinases in human choroidal neovascular membranes excised following verteporfin photodynamic therapy. Br J Ophthalmol (2007) 0.89
Plasma nicotine concentration and the white blood cell count in smokers. Thorax (1986) 0.88
In vitro reoxygenation following hypoxia increases MMP-2 and TIMP-2 secretion by human umbilical vein endothelial cells. Acta Biochim Pol (2010) 0.88
Prevalence of diabetic retinopathy and evaluation of risk factors. A review of 1,005 diabetic clinic patients. S Afr Med J (1988) 0.86
Nicotine promotes contribution of bone marrow-derived cells to experimental choroidal neovascularization in mice. Exp Eye Res (2008) 0.83
Smoking and progression of diabetic nephropathy in type 1 diabetes. Diabetes Care (2003) 0.83
Influence of nicotine and cotinine on retinal phospholipase A2 and its significance to macular function. J Ocul Pharmacol Ther (1998) 0.82
Effects of nicotine and lipopolysaccharide on the expression of matrix metalloproteinases, plasminogen activators, and their inhibitors in human osteoblasts. Arch Oral Biol (2008) 0.80
Lifestyle choices and endothelial function: risk and relevance. Curr Vasc Pharmacol (2009) 0.80
The effects of growth factors on the proliferation and in vitro angiogenesis of human macular inner choroidal endothelial cells. Br J Ophthalmol (2008) 0.80
The involvement of matrix metalloproteinases 2 and 9 in rat retinal ischemia. Graefes Arch Clin Exp Ophthalmol (2006) 0.80
Retinal vascular development and pathologic retinal angiogenesis are not impaired in matrix metalloproteinase-2 deficient mice. Curr Eye Res (2005) 0.79
High-yielding enzymatic method for isolation and culture of microvascular endothelial cells from bovine retinal blood vessels. Microvasc Res (2009) 0.79
Diabetic retinopathy: treating systemic conditions aggressively can save sight. Cleve Clin J Med (2005) 0.77
Macular degeneration: types, causes, and possible interventions. Geriatr Nurs (2007) 0.77
Risk factors for progression of microvascular complications in the Stockholm Diabetes Intervention Study (SDIS). Diabetes Res Clin Pract (1992) 0.76
Prohibitin induces the transcriptional activity of p53 and is exported from the nucleus upon apoptotic signaling. J Biol Chem (2003) 2.52
Nicotinic acetylcholine receptors in cancer: multiple roles in proliferation and inhibition of apoptosis. Trends Pharmacol Sci (2008) 1.90
Determinants of employee participation in physical activity: critical review of the literature. AAOHN J (2006) 1.67
Nicotine increases in vivo blood-brain barrier permeability and alters cerebral microvascular tight junction protein distribution. Brain Res (2004) 1.48
How novel is too novel? Stream community thresholds at exceptionally low levels of catchment urbanization. Ecol Appl (2011) 1.41
Prohibitin facilitates cellular senescence by recruiting specific corepressors to inhibit E2F target genes. Mol Cell Biol (2006) 1.38
Occupational stress, job satisfaction and job performance among hospital nurses in Kampala, Uganda. J Nurs Manag (2011) 1.29
Chronic inflammatory pain leads to increased blood-brain barrier permeability and tight junction protein alterations. Am J Physiol Heart Circ Physiol (2005) 1.28
Fluorescence imaging of blood-brain barrier disruption. J Neurosci Methods (2005) 1.19
Peripheral inflammatory hyperalgesia modulates morphine delivery to the brain: a role for P-glycoprotein. J Neurochem (2007) 1.18
Mannitol opening of the blood-brain barrier: regional variation in the permeability of sucrose, but not 86Rb+ or albumin. Brain Res (2004) 1.13
Tight junctions contain oligomeric protein assembly critical for maintaining blood-brain barrier integrity in vivo. J Neurochem (2007) 1.12
A small molecule disruptor of Rb/Raf-1 interaction inhibits cell proliferation, angiogenesis, and growth of human tumor xenografts in nude mice. Cancer Res (2008) 1.08
Angiogenic activity of nicotinic acetylcholine receptors: implications in tobacco-related vascular diseases. Pharmacol Ther (2008) 1.05
Glycopeptides related to beta-endorphin adopt helical amphipathic conformations in the presence of lipid bilayers. J Am Chem Soc (2005) 1.03
Antinociceptive structure-activity studies with enkephalin-based opioid glycopeptides. J Pharmacol Exp Ther (2004) 1.03
Inhibition of cholinergic signaling causes apoptosis in human bronchioalveolar carcinoma. Cancer Res (2012) 1.02
Protection against hypoxia-induced increase in blood-brain barrier permeability: role of tight junction proteins and NFkappaB. J Cell Sci (2003) 1.01
Comparative changes in the blood-brain barrier and cerebral infarction of SHR and WKY rats. Am J Physiol Regul Integr Comp Physiol (2007) 1.00
Decreased blood-brain barrier permeability to fluorescein in streptozotocin-treated rats. Neurosci Lett (2006) 1.00
Capsaicin displays anti-proliferative activity against human small cell lung cancer in cell culture and nude mice models via the E2F pathway. PLoS One (2010) 0.99
Nicotine induces the up-regulation of the α7-nicotinic receptor (α7-nAChR) in human squamous cell lung cancer cells via the Sp1/GATA protein pathway. J Biol Chem (2013) 0.98
Pathophysiology of the blood-brain barrier: animal models and methods. Curr Top Dev Biol (2008) 0.96
Nociceptive inhibition prevents inflammatory pain induced changes in the blood-brain barrier. Brain Res (2008) 0.93
MG624, an α7-nAChR antagonist, inhibits angiogenesis via the Egr-1/FGF2 pathway. Angiogenesis (2011) 0.92
Modulation of cerebral microvascular permeability by endothelial nicotinic acetylcholine receptors. Am J Physiol Heart Circ Physiol (2005) 0.91
Chromatin immunoprecipitation assays: analyzing transcription factor binding and histone modifications in vivo. Methods Mol Biol (2009) 0.91
Watershed land use is strongly linked to PCBs in white perch in Chesapeake Bay subestuaries. Environ Sci Technol (2004) 0.91
Biphasic cytoarchitecture and functional changes in the BBB induced by chronic inflammatory pain. Brain Res (2006) 0.90
Induction of human metallothionein 1G promoter by VEGF and heavy metals: differential involvement of E2F and metal transcription factors. Oncogene (2005) 0.89
Empirical models based on the universal soil loss equation fail to predict sediment discharges from Chesapeake Bay catchments. J Environ Qual (2008) 0.87
Protection against hypoxia-induced blood-brain barrier disruption: changes in intracellular calcium. Am J Physiol Cell Physiol (2003) 0.85
Capsaicin induces apoptosis in human small cell lung cancer via the TRPV6 receptor and the calpain pathway. Apoptosis (2014) 0.83
A paradigm shift for evaluating pharmacotherapy for Alzheimer's disease: the 10-patient screening protocol. Consult Pharm (2013) 0.82
Pain disability among older adults with arthritis. J Aging Health (2005) 0.81
Pluronic p85 block copolymer enhances opioid peptide analgesia. J Pharmacol Exp Ther (2002) 0.81
Health disparities in rural areas: the interaction of race, socioeconomic status, and geography. J Health Care Poor Underserved (2010) 0.81
Work environment stressors, social support, anxiety, and depression among secondary school teachers. AAOHN J (2010) 0.81
Conjugation of low molecular weight poly(ethylene glycol) to biphalin enhances antinociceptive profile. J Pharm Sci (2003) 0.81
Relationship of blood pressure self-monitoring, medication adherence, self-efficacy, stage of change, and blood pressure control among municipal workers with hypertension. Workplace Health Saf (2012) 0.80
Prevalence of blood pressure self-monitoring, medication adherence, self-efficacy, stage of change, and blood pressure control among municipal workers with hypertension. Workplace Health Saf (2012) 0.79
Nicotinic acetylcholine receptor signaling in atherogenesis. Atherosclerosis (2012) 0.78
Predictors of exercise participation in female hospital nurses. J Adv Nurs (2006) 0.77
Chromatin immunoprecipitation assays: analyzing transcription factor binding and histone modifications in vivo. Methods Mol Biol (2015) 0.76
Data security in occupational health. AAOHN J (2008) 0.75
Policy perspectives on occupational stress. Workplace Health Saf (2014) 0.75
Sleep deprivation and error in nurses who work the night shift. J Nurs Adm (2014) 0.75